Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban

J Thromb Haemost. 2012 Jul;10(7):1433-6. doi: 10.1111/j.1538-7836.2012.04784.x.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Anticoagulants / blood
  • Anticoagulants / pharmacology*
  • Blood Coagulation / drug effects*
  • Blood Coagulation Tests / standards*
  • Calibration
  • Chromogenic Compounds / standards
  • Drug Monitoring / standards*
  • Factor Xa Inhibitors*
  • Humans
  • Morpholines / blood
  • Morpholines / pharmacology*
  • Observer Variation
  • Predictive Value of Tests
  • Prothrombin Time / standards
  • Reference Standards
  • Reproducibility of Results
  • Rivaroxaban
  • Thiophenes / blood
  • Thiophenes / pharmacology*

Substances

  • Anticoagulants
  • Chromogenic Compounds
  • Factor Xa Inhibitors
  • Morpholines
  • Thiophenes
  • Rivaroxaban